Novartis Sells Swiss Manufacturing Plant to Lonza

GALWAY, IRELAND--January XX, 2019--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Swiss pharmaceutical company Novartis International AG (NYSE:NVS) (Basel, Switzerland) has offloaded its sterile drug product fill and finish facility in Stein, Switzerland, to Lonza Group (Basel, Switzerland).

Within this article: Details sale of Swiss plant, activities at plant, future uses, Novartis' global changes to manufacturing and product refocusing